Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,611.83
(
0.44%
)
US TECH 100
23,526.80
(
0.55%
)
Dow Jones
46,669.88
(
0.36%
)
Brent Oil
107.07
(
-1.93%
)
Bitcoin
69,828.25
(
1.19%
)
News Focus
News Focus
Post# of 3757
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

go seek

Send PM Follow Ignore
Followers 23
Posts 5146
Boards Moderated 0
Alias Born 06/24/2006

go seek

Re: None

Tuesday, 12/11/2007 10:18:02 PM

Tuesday, December 11, 2007 10:18:02 PM

Post# of 3757
One would think the Sebivo launches in Europe will be a major plus for IDIX... given JP said sales in Europe were better than in US. That said, i as surprised to hear (recently) that some G5 launches had not yet occurred.

Also the Tyzeka royalties by YE 2008 could be substantial...

> expected IDIX news in the near term
4Q07: Preliminary data from IDX899 phase-1b trial.

4Q07: File IND for IDX102 or IDX184 second-generation HCV nucleoside analogs.




The creation of a thousand forests is in one acorn.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote